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Abstract
Background: The literature provides several studies on the effects of cocaine when exposed to the fetus. However, the majority of these data comes from animal 
models. Objective: The objective of this study is to present socio-demographic and clinical data in crack-cocaine using pregnant women and their babies, as 
compared to non-users. Methods: Cross-sectional study, comprised by 56 dyads of crack-cocaine using mothers-babies and 89 control dyads. In addition to the 
socio-demographic data and the babies’ information, data collection was based on ABIPEMI for socioeconomic level, WAIS for IQ, MINI for psychopathology and 
ASSIST for drug use. Results: Most crack users, in comparison to non-users, did not have a partner (10.52% vs 4.4%, P = 0.001) and presented lower IQ (78.15, 
+/-8.07 vs 84.27 +/- 9.87; P = 0.002). The prevalence of antisocial personality disorder and suicide risk in users was higher than in non-users (24.44% vs none, P 
< 0.001; 28.26% vs 10.46% P = 0.01). Most of the users did not participate in prenatal care (75%). The babies that the crack-cocaine using mothers gave birth to 
weighed significantly less than the controls (2.858 g vs 3.240 g, P = 0.002). Discussion: Users had a higher degree of psychopathology and lower attendance in 
prenatal care. There was an overlap of adverse factors, both for exposed mothers and babies. The sum of these vulnerabilities could result in significant harm to 
the developing infant. 
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Introduction
Due to cocaine’s low molecular weight, its metabolites easily cross 
the placenta, reaching fetal tissues in high concentrations1, with 
concerning effects for child development2. The literature provides 
several studies on the effects of cocaine when exposed to the fetus. 
However, the majority of these data comes from animal models. 
Moreover, data on crack-cocaine specifically in humans are scarce, 
since most studies refer solely to cocaine. The health care provided 
to crack-cocaine using pregnant women represents an opportunity 
for preventive work, reducing costs and promoting better health 
conditions for the respective children. Unfortunately, treatment re-
tention is very low among crack-cocaine users3,4, which compromises 
the prenatal care for the exposed babies. Therefore, services should 
be tailored specifically to this population; while knowledge of their 
characteristics is essential to this end. 
The aim of this article is to present preliminary data on sociode-
mographic and clinical characteristics of crack-cocaine using women 
and their infants in comparison to controls. 
Methods 
This is a cross-sectional study, with a convenience sample comprised 
by 56 dyads of crack-cocaine users and 89 non-exposed dyads. The 
sample was recruited during 2012 and 2013 from Hospital Materno 
Infantil Presidente Vargas (HMIPV) and Hospital de Clínicas de 
Porto Alegre (HCPA). Both are hospitals of reference for high-risk 
prenatal care in the city of Porto Alegre, Brazil. The pregnant women 
were recruited when arriving at the hospital to give birth. During 
the study period, there were 2228 deliveries, and 96 crack-cocaine 
users were identified (crack-cocaine prevalence during pregnancy, by 
interview = 4.4%). We were able to enroll 56 participants (58%), since 
there was not research assistant available full time. We compared 
socio-demographic data from crack-cocaine mothers who entered 
the studied and those who did not, and found no significant differ-
ence for P < 0.05 between groups. The healthy pregnant mothers 
were recruited from a group of donors of umbilical cord blood for 
the blood bank of the HCPA. Data were collected by trained research 
assistants. The project was approved by the Research Ethics Com-
mittee of HCPA and all subjects signed the informed consent form. 
The socio-demographic data collected from the mothers were: 
age, ethnicity, marital status and socio economic level (Brazilian As-
sociation of Market Research Institutes)5. IQ was measured by way of 
the Wechsler Adult Intelligence Scale (WAIS)6 and psychopathology 
by way of the Mini International Neuropsychiatric Interview (MINI) 
Brazilian Version 5.0.0/DSM IV/Current7. The use of crack and other 
drugs was evaluated with ASSIST8. A review of the babies’ medical 
chart was performed to assess birth weight and legal custody after 
discharge, as well as the presence of prenatal care and infectious 
diseases carried by the mothers. 
Results 
Sample characteristics are exhibited in table 1. There was no differ-
ence between groups in terms of age, number of miscarriages and 
fetal death (P ≥ 0.05). In the same manner, there was no difference 
between the crack-cocaine user and control groups in terms of the 
birth being planned or not. Most crack users did not have a partner 
(P = 0.001) and had additional children (P = 0.007). Furthermore, 
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crack users had a greater number of gestations and premature births, 
while having a lower estimated IQ. The crack users also tended to 
belong to a lower socioeconomic level and were more frequently of 
a non-white ethnicity (P ≤ 0.05 for all). Ethanol and tobacco con-
sumption were frequent during the pregnancies of the crack using 
group, and more prevalent among users than non-users (Table 1).
Table 1. Socio-demographic and psychiatric characteristics of a sample of crack 
user pregnant women (n = 56) in comparison to healthy pregnant women (n = 89)
Characteristics
Crack users Controls
P
Mean & SD N % Mean & SD N %
Age 26.58 (5.02) 26.27 (6.) 0.76
Was pregnancy desired?
Yes
No
24 (47.1)
27 (52.9)
34 (38.6)
54 (61.4)
0.37
Number of gestations* 4 (1-5) 2 (1-5) < 0.001
Number of live children* 3 (1-5) 2 (1-5) < 0.001
Number of premature* 0 (0-4) 0 (0-2) < 0.001
Number of miscarriages 0 (0-3) 0 (0-2) 0.123
Fetal death
Yes
No
3 (7.3)
38 (92.7)
9 (12.9)
61 (87.1)
0.53
IQ 78.15 (8.07) 84.27 (9.87) 0.002
White ethnicity
Non-white ethnicity
14 (31.8)
30 (68.2)
66 (75.9)
21 (24.1)
< 0.001
With partner
Without partner 
34 (89.47)
4 (10.52)
85 (95.5)
4 (4.4)
< 0.001
Dichotomized socio 
economic level
A-C
D,E
27 (58.69)
19 (41.3)
79 (89.77) 
9 (10.22) 
< 0.001
Behavior characteristics N (%) N (%) P
Current suicide risk 13 (28.26) 9 (10.46) 0.01
Anti-social** personality 11 (24.44) - 0.00
Frequency of use of nicotine 
and alcohol in the last 3 
months
N (%) N (%) P
Nicotine** 
– Daily or weekly 
– Monthly, once or twice 
and never 
23 (79.31)
6 (20.68)
12 (29.26)
29 (70.73)
< 0.001
Alcohol**
– Daily or weekly 
– Monthly, once or twice 
and never 
11 (40.74)
16 (59.25)
1 (1.7)
57 (98.27)
< 0.001
Student’s t test for independent samples; chi-square test.
SD: standard deviation; * Medium, minimum and maximum; IQ: intelligence quotient; ** Fisher’s 
Exact Test. 
(42.86%) had some infectious disease diagnosed at the hospitaliza-
tion (HIV, Hepatitis C and/or Syphilis). With regard to the babies, 
those born from crack-cocaine using mothers weighed significantly 
less than the controls (2.858 g vs 3.240 g, respectively, P = 0.002). 
We have data regarding the custody for 12 crack exposed babies: 
two of them were allowed to stay with the mother and 10 others 
with family members. 
Discussion 
Most crack users did not have a partner (P = 0.001) and most of 
the fathers in the exposed group were also drug addicts, which can 
represent a weak support matrix, a classical framework of insecure 
attachment with the baby9. In this sense, it was surprising that 47.1% 
(n = 24) of the pregnancies of the crack users were described as 
planned. Could this be a result of the difficulty in making realistic 
plans? An attempt to make up for lost children? Is it possibility an 
attempt to seek greater social support by way of the pregnancy? All 
of which offer possible explanations. Most of the exposed newborns 
were not discharged with their mothers, but with another family 
member. As the literature has documented serious concerns in re-
gards to the situation of these children already10.
There was a significant difference between users and non-users 
regarding suicide risk and anti-social personality. We did not find 
significant differences for other mental disorders, which may also be 
masked by the use of drugs. 
Another important finding was that most of the patients used 
multiple drugs, especially alcohol and tobacco. Both of these drugs 
have been implicated in mental disorders for the developing child, 
like mental retardation in the case of alcohol abuse11. Thus, although 
the effects of prenatal cocaine exposure remains unclear12,13, since its 
use is frequently associated to alcohol and tobacco, it puts the baby 
at risk. Interestingly, some subjects tried to decrease crack-cocaine 
use during pregnancy, highlighting this period as a time of greater 
receptivity to therapeutic intervention14. 
Our study has limitations, such as the use of a convenience sample 
–what might be acceptable in studies with difficult to reach subjects. 
We did not have data on infectious disease and some other variables 
for all of the subjects of the crack risk user group, because they often 
did not undergo prenatal appointments. For many variables there is 
missing data, since the mothers, despite having accepted to partici-
pate in the study, were not willing to respond to all the questions, 
because of abstaining from drug use or because of the post-partum. 
In addition, it is the right of the participant not to respond to ques-
tions that create stress or are overwhelming, considering that this 
study was carried out at a very difficult moment for the mother, 
both physically and emotionally. Another limitation is the fact that 
the control group was not comprised of peers with the same social 
characteristics. However, all participants whether crack users or from 
the control group, were users of the SUS (Brazilian Public Healthcare 
System). On the other hand, our study has strengths, such as the use 
of well-established instruments and the description of crack-cocaine 
using pregnant women, which is scarce in the literature. Nevertheless, 
the present study found a highly vulnerable population of pregnant 
women, in social and mental terms, exposing their babies to a series 
of hardships, beginning in the intra-uterus period. One of the most 
relevant findings was the high rate of absence in the prenatal care of 
the users (75%), as well as the high rate of infectious diseases. Our 
data highlights the need for a more active process in the engagement 
of this special population in both prenatal care and drug treatment, 
favoring post-partum conditions, such as trying to avoid mother-
baby separation, stimulating breast feeding, in order to build secure 
attachment15. This approach, rarely offered by public health care 
worldwide, could help to promote primary prevention in childhood. 
Acknowledgments
This study was funded by Coordenação de Aperfeiçoamento de 
Pessoal de Nível Superior (Capes), Fundação de Amparo à Pesquisa 
Of the pregnant crack using mothers, there is information about 
13 of the babies’ fathers, out of which 7 (54%) were also crack-cocaine 
users, whereas there was no report of the fathers’ substance use in 
the control group. 
There is information about crack use in the last 3 months prior 
to the interview for 29 out of the 56 users (51.78%): of these 29, 14 
users (48.27%) admitted daily or almost daily use of crack-cocaine, 
5 (17.29%) weekly use, 3 (10.34%) monthly use, 3 (10.34%) once or 
twice and 4 (13.79%) no use during the last three months. Accord-
ing to ASSIST, 7 pregnant users tried to reduce the intake of crack 
in the last 3 months and another 5 did tried to, but not during the 
last 3 months. 
From the crack-cocaine users, most of them did not have any 
prenatal appointment (75%). As a result of this fact, there was 
information about infectious diseases for only 14 (25%) mothers 
of the case group. From this group of 14 crack using mothers, 6 
123Zavaschi MLS et al. / Arch Clin Psychiatry. 2014;41(5):121-3
6. Wechsler David. WAIS-III: Escala de Inteligência Wechsler para adultos: 
manual. 3ª ed. Adaptação e padronização de uma amostra brasileira. 
Tradução: Maria Cecília de Vilhena Moraes Silva. São Paulo: Casa do 
Psicólogo; 2004. 
7. Amorin P. Mini International Neuropsychiatric interview (MINI): vali-
dação de entrevista breve para diagnóstico de transtornos mentais. Rev 
Bras Psiquiatr. 2000;22(3):106-15.
8. Henrique IFS, De Micheli D, Lacerda RB, Lacerda LA, Formigoni MLOS. 
Validação da versão brasileira do teste de triagem do envolvimento com 
álcool, cigarro e outras substâncias (ASSIST). Rev Assoc Med Bras. 
2004;50(2);199-206.
9. Roque L, Veríssimo M, Fernandes M, Rebelo A. Emotion regulation and 
attachment: relationships with children’s secure base, during different 
situational and social contexts in naturalistic settings. Infant Behav Dev. 
2013;36(3):298-306. 
10. Koren G. Water by the spoonful: children of addiction. Can Fam Phy-
sician. 2013;59(3):e141-2.
11. O’Leary C,  Leonard H,  Bourke J,  D’Antoine H,  Bartu A,  Bower C. 
Intellectual disability: population-based estimates of the proportion 
attributable to maternal  alcohol  use disorder during  pregnancy. Dev 
Med Child Neurol. 2013;55(3):271-7.
12. Bennett DS, Bendersky M, Lewis M. Children’s cognitive ability from 4 
to 9 years old as a function of prenatal cocaine exposure, environmental 
risk, and maternal verbal intelligence. Dev Psychol. 2008;44(4):919-28.
13. Richardson GA, Goldschmidt L, Willford J. The effects of prenatal cocaine 
use on infant development. Neurotoxicol Teratol. 2008;30(2):96-106.
14. Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse 
treatment programming for women: a review. Am J Drug Alcohol Abuse. 
2003;29(1):19-53.
15. Suchman NE,  DeCoste C,  Leigh D,  Borelli J. Reflective functioning 
in mothers with drug use disorders: implications for dyadic interactions 
with infants and toddlers. Attach Hum Dev. 2010;12(6):567-85.
do Estado do Rio Grande do Sul (Fapergs) and by the Fundo de 
Incentivo à Pesquisa e Eventos (Fipe) of the Hospital de Clínicas de 
Porto Alegre (HCPA). All Brazilian institutions. 
Disclosure
Dr. Szobot has been a member of the speakers’ bureau of Novartis 
in the last 3 years. Dr. Luis A. Rohde was on the speakers’ bureau 
and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis, and 
Shire in the last 3 years. The ADHD and Juvenile Bipolar Disorder 
Outpatient Programs chaired by LR received unrestricted educational 
and research support from Treatment of adults with ADHD with the 
following pharmaceutical companies in the last 3 years: Eli-Lilly, 
Janssen-Cilag, Novartis, and Shire. Dr. Pechansky and other authors: 
no private conflict of interest to declare. 
References 
1. Riezzo I, Fiore C, De Carlo D, Pascale N, Neri M, Turillazzi E, et al. Side 
effects of cocaine abuse: multiorgan toxicity and pathological consequen-
ces. Curr Med Chem. 2012;19(33):5624-46.
2. Cambell S. Prenatal cocaine exposure and neonatal/infant outcomes. 
Neonatal Netw. 2003;22(1):19-21.
3. Lester BM, Twomey, JE. Treatment of substance abuse during pregnancy. 
Womens Health (Lond Engl). 2008;4(1):67-77. 
4. Weisdorf T, Parran TV Jr, Graham A, Snyder C. Comparison of preg-
nancy-specific interventions to a traditional treatment program for co-
caine-addicted pregnant women. J Subst Abuse Treat. 1999;16(1):39-45.
5. Mattar FN. Análise crítica dos estudos de estratificação socioeconômica 
da ABA-Abipeme. Rev Administr. 1995;30(1):57-74.
